The aim of this study is to compare treatment informed by ctDNA results to standard care in patients with stage III colon cancer.
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study (DYNAMIC-III).
|Eligibility criteria|| |
Stage III Colon Cancer.
|Study details|| |
The study aims to investigate if taking serial blood samples monitoring for tumour cells can improve treatment for patients curatively treated for colon cancer.
|Further information|| |
For more information regarding this clinical trial click here.
North Shore NSW